Menu

HHMI to Fund International Labs

Twenty-eight international scientists win HHMI funding to set up own research labs overseas.

Jan 25, 2012
Sabrina Richards

WIKIMEDIA COMMONS, URI BARUCHIN

The Howard Hughes Medical Institute (HHMI) announced yesterday (January 24) that it will fund 28 young scientists in international labs to the tune of $20 million, reported ScienceInsider. Created to help US-trained scientists establish laboratories abroad, the first International Early Career Scientist grants were awarded to 28 researchers in countries that lack robust research funding despite adequate infrastructure to support science. The recipients, who will receive $100,000 per year for 5 years plus $150,000 to purchase lab equipment, can apply for renewed funding after 5 years.

Biographies of winners can be viewed at HHMI’s website. More information on winners will be posted at Science Careers on Thursday after 2 p.m.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.